EcoDrugPlus

Ribosomal Protein S9

Ensembl ID : ENSOKIG00005011060
Gene Symbol: RPS9
3 Cross references
232 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSOKIG00005000468
Gene Symbol: RPLP0
1 Cross references
392 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSOKIG00005013737
Gene Symbol: LOC109882485
3 Cross references
184 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSOKIG00005047114
Gene Symbol: LOC109896112
3 Cross references
184 Possible Orthologues:

Serine/threonine-Protein Kinase B-Raf

Ensembl ID : ENSOKIG00005030523
Gene Symbol: LOC109886565
3 Cross references
216 Possible Orthologues:

Serine/threonine-Protein Kinase B-Raf-Like

Ensembl ID : ENSOKIG00005045074
Gene Symbol: LOC109886565
3 Cross references
216 Possible Orthologues:

Serine/threonine-Protein Kinase D3-Like

Ensembl ID : ENSOKIG00005038496
Gene Symbol: LOC109866396
2 Cross references
195 Possible Orthologues:

Serine/threonine-Protein Kinase Plk4

Ensembl ID : ENSOKIG00005005624
Gene Symbol: LOC109904092
3 Cross references
208 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1

Ensembl ID : ENSOKIG00005005744
Gene Symbol: LOC109908011
3 Cross references
240 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1

Ensembl ID : ENSOKIG00005023060
Gene Symbol: LOC109869251
3 Cross references
239 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-3

Ensembl ID : ENSOKIG00005025449
Gene Symbol: LOC109897768
3 Cross references
152 Possible Orthologues:

Serpin Peptidase Inhibitor, Clade C (Antithrombin), Member 1

Ensembl ID : ENSOKIG00005016276
Gene Symbol: SERPINC1
1 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).